e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New therapeutic strategies in BOS
G. Verleden (Leuven, Belgium)
Source:
Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Session:
Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Session type:
Symposium
Number:
4393
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Verleden (Leuven, Belgium). New therapeutic strategies in BOS. Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Acute viral bronchiolitis and acute asthma
Related content which might interest you:
Old and new therapeutic options in BOS
Source: School Course 2012 - Lung Transplantation
Year: 2012
New therapeutic targets
Source: Annual Congress 2007 - COPD – a disease of accelerated ageing?
Year: 2007
New treatment approaches for IPF
Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
Year: 2016
New treatment strategies in AATD
Source: Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Year: 2013
New perspectives in PGD prevention and treatment
Source: School Course 2012 - Lung Transplantation
Year: 2012
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
New methodologogic approaches to the management of antituberculous service
Source: Eur Respir J 2003; 22: Suppl. 45, 381s
Year: 2003
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
New mechanisms and targets in COPD
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014
Current and future preventive and treatment strategies in CLAD
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015
New horizons in ventilator development
Source: ERS Course 2018 - Noninvasive ventilation: advanced
Year: 2018
New perspectives in MDR-TB management
Source: International Congress 2016 – China Session II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept